Skip to main content

Table 2 The clinical characteristics of study participants and their relationship to renal impairment (n = 421)

From: The association between renal impairment and polypharmacy among older Palestinian patients: a multi-center cross-sectional study

 

Total

Renal Impairment

P-value*

Frequency (%)

Yes (127)

Frequency (%)

No (284)

Frequency (%)

eGFR (Mean ± SD)

69 ± 19.5

46.3 ± 11.1 5

79.9 ± 12.3

 

PHC visits (last three months)

 one visit/ 3 months

54(12.8%)

17 (31.5%)

37 (68.5%)

.467

 More than one visit /3 months

367(87.2)

110 (30.0%)

257 (70.0%)

 

Source of medication

  

.013

 One PHC clinic

168(39.9%)

40(23.8%)

128(76.2%)

 

 More than one PHC clinic

253(60.1%)

87(34.4%)

166(65.6%)

 

Diabetes Mellitus

 Yes

237(56.0%)

75 (31.6%)

162 (68.4%)

.521

 No

184(43.7%)

52 (28.3%)

132 (71.7%)

 

Heart diseases

 Yes

154(36.6%)

46 (29.9%)

108 (70.1%)

.505

 No

267(63.4%)

81 (30.3%)

186 (69.7%)

 

Hypertension

 Yes

357 (84.8%)

117 (32.8%)

10 (15.6%)

.005

 No

64 (15.2%)

10 (15.6%)

54 (84.4%)

 

Stroke

 Yes

40 (9.5%)

18(45.0%)

22(55.0%)

.027

 No

381(90.5%)

109(28.6%)

272(71.4%)

 

Polypharmacy

 Less than 5

105(24.9%)

19 (18.1%)

86 (81.9%)

<.001

 5–9

281(66.7%)

88 (31.3%)

193 (68.7%)

 

 More than 10

35 (8.3%)

20 (51.4%)

15 (48.6%)

 

Hospitalization (last two years)

 Yes

107(25.4%)

38 (35.5%)

225 (71.7%)

.163

 No

314(74.6%)

89 (64.5%)

69 (64.5%)

 
  1. eGFR Estimated glomerular filtration rate, PHC Primary Health Care